Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Mikhelson confirms Sibur's preparation for IPO

12/5/24 SIBR

Novatek will further develop LNG projects

12/5/24 NVTK

Rosneft has scheduled the first stage of commissioning of the Vostok Oil project for 2026

12/5/24 ROSN

VTB to acquire about 30 suppliers of equipment for OSK

12/5/24 VTBR

Delimobile opened a showroom for the sale of used cars

12/5/24 DELI

VTB to launch its own DFA platform

12/5/24 VTBR

Shareholders of Europlan approved dividends

12/5/24 LEAS

VTB to close its banking business in Africa

12/5/24 VTBR

Astra acquired the Botsman containerization platform

12/5/24 ASTR

M.video-Eldorado started to issue microloans

12/5/24 MVID